Skip to main content
Medical information Clinical review pending

Genetic Testing

Foxg1 Gene Rett Syndrome Congenital Variant Genetic Test

Genetic test to identify mutations in the FOXG1 gene associated with Rett Syndrome, a neurodevelopmental disorder. Helps in early diagnosis and management.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (EDTA tube), Extracted DNA, or One drop of blood on FTA Card.
Results
Approximately 3 to 4 weeks. Confirm with the laboratory before booking.
Preparation
A genetic counseling session is recommended before the test to discuss clinical history and family pedigree.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Foxg1 Gene Rett Syndrome Congenital Variant Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Suspected Rett Syndrome based on clinical symptoms.
  • ✓Developmental delay or regression.
  • ✓Loss of purposeful hand skills.
  • ✓Family history of Rett Syndrome or FOXG1 mutations.
  • ✓Seizures or gait abnormalities in infancy or early childhood.
  • ✓Genetic counseling for families with affected members.
02

In plain language

What this test helps you understand

Identifies mutations in the FOXG1 gene associated with Rett Syndrome, aiding in diagnosis, prognosis, and genetic counseling.
The Foxg1 Gene Rett Syndrome Congenital Variant NGS Genetic DNA Test is a diagnostic tool used to identify mutations in the FOXG1 gene. Mutations in this gene are linked to Rett Syndrome, a severe neurodevelopmental disorder that primarily affects females. This test uses Next-Generation Sequencing (NGS) technology for accurate genetic analysis.

This test specifically looks for changes in the FOXG1 gene, which is important for brain development. Detecting these mutations can help healthcare providers understand the genetic cause of Rett Syndrome in individuals.

Individuals showing symptoms of Rett Syndrome or those with a family history of the condition may benefit from this test. Symptoms can include loss of purposeful hand skills, developmental delays, seizures, and gait abnormalities. Families with a known history of FOXG1 mutations are also encouraged to consider testing.

Benefits of this test include accurate diagnosis, enabling tailored treatment plans and early intervention strategies. It can also provide information for family planning.

Results will be explained by healthcare professionals to help understand the implications and next steps for management and support.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationA genetic counseling session is recommended before the test to discuss clinical history and family pedigree.
SampleBlood sample (EDTA tube), Extracted DNA, or One drop of blood on FTA Card.
MethodologyNext-Generation Sequencing (NGS) of the FOXG1 gene.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test specifically analyzes the FOXG1 gene. It does not detect mutations in other genes that may cause similar symptoms. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Rett Syndrome is a rare genetic neurological and developmental disorder that affects the way the brain develops, causing a progressive loss of motor skills and speech.
Individuals exhibiting symptoms consistent with Rett Syndrome, such as developmental regression, loss of hand skills, or seizures, should consider this test. A family history of Rett Syndrome is also an indication.
The test involves analyzing a sample of your DNA (usually from a blood sample) to look for specific changes (mutations) in the FOXG1 gene.
Results are interpreted by genetic specialists and explained to you by your doctor or a genetic counselor. They will discuss the findings and their implications.
Yes, a genetic counseling session before the test is recommended to discuss your medical history, family history, and the purpose of the test.
A blood sample, extracted DNA, or a single drop of blood on an FTA card can be used for this test.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp